Parkinson

Israeli man facing early-onset Alzheimer's develops potential treatment for Parkinson's disease

Initially turned away, Ofer Shina built X-tosis around Prof. Varda Shoshan-Barmatz's research. The startup has a $2.74 million Michael J. Fox Foundation grant and is initially targeting Parkinson's.

Prof. Varda Shoshan-Barmatz in her lab at Ben-Gurion University of the Negev, where her research on the protein VDAC1 led to the founding of X-tosis.
 Alan Greenspan.

Alan Greenspan, Jewish economist, longtime head of Federal Reserve, dies at 100

Making Parkinson's cure personal: TechBio co-founder Micha Breakstoneand developmental biologist Olivier Pourquie.

AI meets biology: How cellular intelligence is redefining stem cell therapy

In this photo illustration, a smartphone displays the logo of Novo Nordisk (NYSE: NVO), a Denmark-based pharmaceutical company specializing in diabetes care, obesity treatment, in front of a screen showing the company's latest stock market chart, January 29, 2026

Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy


Poor sense of smell linked to increased risk of depression in older adults - study

While loss of smell is not thought to cause depression, a new study shows that it may serve as a potent indicator of overall health and well-being.

 A man's nose

Elite soccer players 1.5 times more likely to develop Alzheimer's -study

A new study aimed to determine the risk of neurodegenerative disease among male players in the top Swedish soccer division Allsvenskan compared to the general population.

Djurgarden's Jonathan Ring in action with Sirius' Karl Larson - Allsvenskan - IK Sirius v Djurgardens IF - Uppsala, Sweden, June 14, 2020

New research uncovers method to prevent DNA breakdown, aging - study

The research focuses on a protein called SIRT6, which seems to have remarkable properties.

 What are the scientific processes behind aging?

US Parkinson's disease incidence far higher than earlier estimates -study

Analysis of insurance claims and population growth indicates higher numbers than previously thought - and they will continue to rise.

 Parkinson's disease (illustrative)

Elon Musk says expects Neuralink to begin human trials in six months

The company is developing brain chip interfaces that it says could enable disabled patients to move and communicate again.

Elon Musk discussing the Neuralink

Shaare Zedek Medical Center treats Parkinsons patients using DBS for first time

Deep Brain Stimulation surgery, known as DBS, is meant to stop tremors in Parkinson's, primary tremors and other neurological diseases.

Shaare Zedek Medical Center.

Man with Parkinson's attacked and robbed in Tel Aviv

The attackers have been indicted by the Tel Aviv District Attorney's Office.

 View of office and apartment highrise buildings in central Tel Aviv, on November 27, 2017

Israeli researchers identify Parkinson's nerve cell processes for first time - study

One of the problems in developing treatments is the fact that only 15% of Parkinson’s cases are caused by known genetic factors.

 Dr. Shani Stern and team members at the University of Haifa

Iron buildup in brain can raise risk of movement disorders - study

Iron overload, usually caused by the genetic condition hereditary hemochromatosis, can cause a wide number of health issues, but this study sheds light on its impact on the brain.

 The brain (illustrative).

Israeli researchers find new molecule that constantly renews cell vitality - study

The promising new molecule, found in diseased tissues by Hebrew University researchers, may eventually prevent age-related diseases like Alzheimer’s and Parkinson’s.

Illustrative photo of two elderly people staring at a beach.